US Stock MarketDetailed Quotes
ADTX Aditxt
- 0.8976
- -0.0524-5.52%
Close Aug 23 16:00 ET
- 0.9500
- +0.0524+5.84%
Post 20:02 ET
3.23MMarket Cap-26P/E (TTM)
0.9800High0.8825Low250.12KVolume0.9407Open0.9500Pre Close228.34KTurnover7.30%Turnover RatioLossP/E (Static)3.60MShares68.080052wk High0.49P/B3.07MFloat Cap0.882552wk Low--Dividend TTM3.43MShs Float19160.0000Historical High--Div YieldTTM10.26%Amplitude0.8825Historical Low0.9120Avg Price1Lot Size
About Aditxt Company
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Company Profile
SymbolADTX
Company NameAditxt
Listing DateJun 30, 2020
Founded2017
CEOMr. Amro A. Albanna
MarketNASDAQ
Employees47
Fiscal Year Ends12-31
Address737 North Fifth Street,Suite 200
CityRichmond
ProvinceVirginia
CountryUnited States of America
Zip Code23219
Phone1-650-870-1200
Websitehttp://www.aditxt.com
Company Executives
- Name
- Position
- Salary
- Amro A. Albanna
- Chairman of the Board and Chief Executive Officer
- 519.23K
- Thomas J. Farley
- Chief Financial Officer and Principal Accounting Officer
- 381.45K
- Dr. Shahrokh Shabahang, D.D.S.,M.S.,PhD
- Director and Chief Innovation Officer
- 358.84K
- Rowena Albanna
- Chief Operating Officer
- --
- Corinne Pankovcin
- Chief Mergers and Acquisitions Officer
- 390.33K
- Dr. Jeffrey W. Runge, M.D.
- Independent Director
- 3.86K
- Charles Athle Nelson
- Independent Director
- --
- Brian Brady
- Independent Director
- 3.86K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg